51 | 5OA0 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
|
0.5 |
SHOW |
52 | 5O87 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.5 |
SHOW |
53 | 5AIN |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
VARENICLINE |
QMR |
|
0.49 |
SHOW |
54 | 6SGV |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
Hosieine |
LDQ |
|
0.49 |
SHOW |
55 | 6CNK |
Neuronal acetylcholine receptor subunit alpha4beta-2 | Homo sapiens |
P17787 (ACHB2_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.49 |
SHOW |
56 | 4ZRU |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
3-[(2S)-pyrrolidin-2-ylethynyl]pyridine |
TI9 |
|
0.49 |
SHOW |
57 | 3SIO |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
METHYLLYCACONITINE |
MLK |
|
0.49 |
SHOW |
58 | 6USF |
Neuronal acetylcholine receptor subunit alpha-4 | Homo sapiens |
P43681 (ACHA4_HUMAN) |
VARENICLINE |
QMR |
|
0.49 |
SHOW |
59 | 3RQW |
Gamma-aminobutyric-acid receptor subunit beta-1 | Dickeya dadantii |
E0SJQ4 (E0SJQ4_DICD3) |
ACETYLCHOLINE |
ACH |
|
0.48 |
SHOW |
60 | 6QQO |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
6-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]pyridine-3-carboxamide |
JC8 |
|
0.48 |
SHOW |
61 | 6QKK |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
4-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]benzamide |
H92 |
|
0.48 |
SHOW |
62 | 6PV7 |
Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens |
P32297 (ACHA3_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.47 |
SHOW |
63 | 5KXI |
Neuronal acetylcholine receptor subunit alpha4beta-2 | Homo sapiens |
P17787 (ACHB2_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.47 |
SHOW |
64 | 5OAL |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
|
0.47 |
SHOW |
65 | 6PV8 |
Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens |
P32297 (ACHA3_HUMAN) |
(3-endo)-N-(2-bromophenyl)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine |
P1M |
|
0.47 |
SHOW |
66 | 5KZU |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
9-[[1-[8-methyl-8-(2-phenylethyl)-8-azoniabicyclo[3.2.1]octan-3-yl]triazol-4-yl]methyl]carbazole |
74S |
|
0.46 |
SHOW |
67 | 3SH1 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
METHYLLYCACONITINE |
MLK |
|
0.46 |
SHOW |
68 | 5FJV |
Neuronal acetylcholine receptor subunit alpha-2 | Homo sapiens |
Q15822 (ACHA2_HUMAN) |
EPIBATIDINE |
EPJ |
|
0.45 |
SHOW |
69 | 5CFB |
Glycine receptor subunit alpha-3 | Homo sapiens |
O75311 (GLRA3_HUMAN) |
STRYCHNINE |
SY9 |
|
0.45 |
SHOW |
70 | 5OBG |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
|
0.45 |
SHOW |
71 | 3JAD |
Glycine receptor subunit alphaZ1 | Danio rerio |
O93430 (GLRA1_DANRE) |
STRYCHNINE |
SY9 |
|
0.44 |
SHOW |
72 | 5BW2 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(2R)-2-(pyridin-3-yl)-1-azabicyclo[2.2.2]octane |
4VU |
|
0.44 |
SHOW |
73 | 6NP0 |
5-hydroxytryptamine receptor 3A | Mus musculus |
P23979 (5HT3A_MOUSE) |
1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide |
CWB |
|
0.43 |
SHOW |
74 | 6CNJ |
Neuronal acetylcholine receptor subunit alpha4beta-2 | Homo sapiens |
P17787 (ACHB2_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.43 |
SHOW |
75 | 1LN1 |
Phosphatidylcholine transfer protein | Homo sapiens |
Q9UKL6 (PPCT_HUMAN) |
1,2-DILINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE |
DLP |
|
0.43 |
SHOW |
76 | 6SH0 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
1-[(1R,6R)-9-azabicyclo[4.2.1]non-2-en-2-yl]ethanone |
4P0 |
|
0.43 |
SHOW |
77 | 2XNU |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
2-(2-(4-PHENYLPIPERIDIN-1-YL)ETHYL)-1H-INDOLE |
VU3 |
|
0.43 |
SHOW |
78 | 6Y1Z |
5-hydroxytryptamine receptor 3A | Mus musculus |
P23979 (5HT3A_MOUSE) |
(3~{a}~{S})-2-[(3~{S})-1-azabicyclo[2.2.2]octan-3-yl]-3~{a},4,5,6-tetrahydro-3~{H}-benzo[de]isoquinolin-1-one |
O7B |
|
0.43 |
SHOW |
79 | 2XNV |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
2-(2-(4-PHENYLPIPERIDIN-1-YL)ETHYL)-1H-INDOLE |
VU3 |
|
0.42 |
SHOW |
80 | 6ETV |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
[3-(2~{H}-1,2,3,4-tetrazol-5-yl)propanoylamino]azanium |
BXE |
|
0.42 |
SHOW |
81 | 5F5A |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
2-[(furan-2-ylmethylamino)methyl]pyridine-4-carboxylic acid |
5V0 |
|
0.42 |
SHOW |
82 | 6X47 |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)-2-naphthonitrile |
7AX |
|
0.41 |
SHOW |
83 | 2ZJU |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitroimidazolidin-2-imine |
IM4 |
|
0.41 |
SHOW |